ShiviJainMD

Clotting Disorder, Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Associate Professor Division of Hematology/Oncology/Cell Therapy Rush University Medical Center.

Overview of Dr. Jain

Dr. Shivi Jain is a hematologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Rush Oak Park Hospital. She received her medical degree from Sawai Man Singh Medical College and has been in practice 12 years. She is one of 22 doctors at Rush University Medical Center and one of 8 doctors at Rush Oak Park Hospital who specialize in Hematology. She also speaks multiple languages, including Hebrew and Hindi. She has more than 20 publications and over 150 citings.

Office
1725 W Harrison street
POB Ste 809
Chicago, IL 60612
Book by Phone+1(872) 326-9391

Fax+1 312-942-3192

Education & Training

Cook County Health and Hospitals SystemFellowship, Hematology and Medical Oncology, 2010 - 2013
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2007 - 2010
Sawai Man Singh Medical CollegeClass of 2005

Certifications & Licensure

IL State Medical License 2007 - 2026
American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

5 citations
Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia.
Shivi Jain, Terry Gernsheimer, Scott Kolodny, Chelsea Bernheisel, Michael Vredenburg
Platelets. 2023-12-01
23 citations
Patterns of opioid use in sickle cell disease
Jin Han, Santosh L. Saraf, Xu Zhang, Michel Gowhari, Robert E. Molokie
American Journal of Hematology. 2016-11-01
18 citations
HMOX1 and acute kidney injury in sickle cell anemia
Santosh L. Saraf, Maya Viner, Ariel Rischall, Rasha Raslan, Binal N. Shah
Blood. 2017-12-07

Abstracts/Posters

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease
Shivi Jain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Cancer Incidence in Sickle Cell Disease:an Institutional Experience
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Mentorship Leads to Research Opportunity, ASH Spotlight for High School StudentDecember 28th, 2020
The Reality of Cancer Incidence in Sickle Cell Disease PatientsFebruary 5th, 2019